BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38309487)

  • 1. In-depth investigation of the therapeutic effect of Tribulus terrestris L. on type 2 diabetes based on intestinal microbiota and feces metabolomics.
    Meng X; Shi M; Guo G; Xing J; Liu Z; Song F; Liu S
    J Ethnopharmacol; 2024 May; 325():117815. PubMed ID: 38309487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.
    Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J
    Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulating the gut microbiota and SCFAs in the faeces of T2DM rats should be one of antidiabetic mechanisms of mogrosides in the fruits of Siraitia grosvenorii.
    Zhang Y; Peng Y; Zhao L; Zhou G; Li X
    J Ethnopharmacol; 2021 Jun; 274():114033. PubMed ID: 33741440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the Mechanism Underlying the Antihypertensive Effects of
    Qi YZ; Yang XS; Jiang YH; Shao LL; Jiang LY; Yang CH
    Biomed Res Int; 2020; 2020():4261485. PubMed ID: 33204695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from
    Shao J; Liu Y; Wang H; Luo Y; Chen L
    Oxid Med Cell Longev; 2020; 2020():1805418. PubMed ID: 32566075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal metabolomics combined with 16S rRNA gene sequencing to analyze the effect of Jiaotai pill intervention in type 2 diabetes mellitus rats.
    Liu J; Wang X; Li Q; Piao C; Fan Z; Zhang Y; Yang S; Wu X
    Front Nutr; 2023; 10():1135343. PubMed ID: 37229468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PuRenDan alleviates type 2 diabetes mellitus symptoms by modulating the gut microbiota and its metabolites.
    Ma X; Qiu Y; Mao M; Lu B; Zhao H; Pang Z; Li S
    J Ethnopharmacol; 2024 Mar; 322():117627. PubMed ID: 38147943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
    Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
    J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effect and mechanism of Jingfang Granules on acute lung injury based on intestinal flora and fecal metabolomics].
    Xiao H; Sun XX; Sun CH; Wang EL; Wang XZ; Yao JC
    Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(7):1915-1923. PubMed ID: 38812204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive fecal metabolomics and gut microbiota for the evaluation of the mechanism of Panax Ginseng in the treatment of Qi-deficiency liver cancer.
    Hou Z; Song F; Xing J; Zheng Z; Liu S; Liu Z
    J Ethnopharmacol; 2022 Jun; 292():115222. PubMed ID: 35341933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jiang-Tang-San-Huang pill alleviates type 2 diabetes mellitus through modulating the gut microbiota and bile acids metabolism.
    Tawulie D; Jin L; Shang X; Li Y; Sun L; Xie H; Zhao J; Liao J; Zhu Z; Cui H; Wen W
    Phytomedicine; 2023 May; 113():154733. PubMed ID: 36870307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated 16S rRNA Sequencing and Untargeted Metabolomics Analysis to Reveal the Protective Mechanisms of
    Zhang H; Li H; Pan B; Zhang S; Su X; Sun W; Zhang T; Zhang Z; Lv S; Cui H
    Curr Drug Metab; 2023; 24(4):270-282. PubMed ID: 37038712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles.
    Zhou R; He D; Zhang H; Xie J; Zhang S; Tian X; Zeng H; Qin Y; Huang L
    J Ethnopharmacol; 2023 Mar; 303():115997. PubMed ID: 36509256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal and serum metabolomic signatures and gut microbiota characteristics of allergic rhinitis mice model.
    Chen Z; He S; Wei Y; Liu Y; Xu Q; Lin X; Chen C; Lin W; Wang Y; Li L; Xu Y
    Front Cell Infect Microbiol; 2023; 13():1150043. PubMed ID: 37180443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cardiac protection of Baoyuan decoction via gut-heart axis metabolic pathway.
    Du Z; Wang J; Lu Y; Ma X; Wen R; Lin J; Zhou C; Song Z; Li J; Tu P; Jiang Y
    Phytomedicine; 2020 Dec; 79():153322. PubMed ID: 32920286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
    Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
    Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats.
    Wang H; Teng Y; Li S; Li Y; Li H; Jiao L; Wu W
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771066
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrated 16S rRNA sequencing and nontargeted metabolomics analysis to reveal the mechanisms of Yu-Ye Tang on type 2 diabetes mellitus rats.
    Ma Z; Sun W; Wang L; Wang Y; Pan B; Su X; Li H; Zhang H; Lv S; Wang H
    Front Endocrinol (Lausanne); 2023; 14():1159707. PubMed ID: 37732114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.